[Guidelines for percutaneous coronary interventions].

ESC Committee for Practice Guidelines (CPG): Silvia G. Priori (Chairperson) (Italy), Maria Angeles Alonso Garcia (Spain), Jean-Jacques Blanc (France), Andrzej Budaj (Poland), Martin Cowie (UK), Veronica Dean (France), Jaap Deckers (The Netherlands), Enrique Fernandez Burgos (Spain), John Lekakis (Greece), Bertil Lindahl (Sweden), Gianfranco Mazzotta (Italy), Keith McGregor (France), João Morais (Portugal), Ali Oto (Turkey), Otto A. Smiseth (Norway)

[1]  S. Garcia,et al.  Correlation of TIMI risk score with angiographic severity and extent of coronary artery disease in patients with non-ST-elevation acute coronary syndromes. , 2004, The American journal of cardiology.

[2]  P. Teirstein,et al.  Five-Year Clinical Follow-Up After Intracoronary Radiation: Results of a Randomized Clinical Trial , 2002, Circulation.

[3]  W. Boden,et al.  Optimal treatment of acute coronary syndromes--an evolving strategy. , 2001, The New England journal of medicine.

[4]  D. Saura,et al.  Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis. , 2004, European heart journal.

[5]  Z. Vered,et al.  Minimal heparinization in coronary angioplasty--how much heparin is really warranted? , 2000, The American journal of cardiology.

[6]  Eugenio Martuscelli,et al.  Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: six-year clinical follow-up of the GISSOC trial. , 2003, Journal of the American College of Cardiology.

[7]  P. Serruys,et al.  CORONARY ARTERY DISEASE Original Studies Clinical Outcomes for Sirolimus-Eluting Stent Implantation and Vascular Brachytherapy for the Treatment of In-Stent Restenosis , 2004 .

[8]  Frans Van de Werf,et al.  Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003 .

[9]  Ameet Bakhai,et al.  Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial , 2004, Circulation.

[10]  Samin K. Sharma,et al.  Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) , 1998, Circulation.

[11]  David J Cohen,et al.  Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation , 2004, Circulation.

[12]  H. White,et al.  Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban , 1999, The Lancet.

[13]  N. Smedira,et al.  Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. , 2004, The American journal of cardiology.

[14]  Mark A Hlatky,et al.  Medical Costs and Quality of Life 10 to 12 Years After Randomization to Angioplasty or Bypass Surgery for Multivessel Coronary Artery Disease , 2004, Circulation.

[15]  S. Ellis,et al.  Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. , 2000, American heart journal.

[16]  M. Schalij,et al.  Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent Study , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  C. Bauters,et al.  Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. , 1998, Circulation.

[18]  S. Pocock,et al.  A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting , 1998 .

[19]  A. Prakash,et al.  Predictors of troponin elevation after percutaneous coronary intervention. , 2004, The American journal of cardiology.

[20]  Jerome Sacks,et al.  Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. , 2002, Journal of the American College of Cardiology.

[21]  M. Morice,et al.  A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. , 2002, Journal of the American College of Cardiology.

[22]  K A Eagle,et al.  ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro , 2001, Journal of the American College of Cardiology.

[23]  E W Steyerberg,et al.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.

[24]  P. Widimsky,et al.  Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. , 2002, European heart journal.

[25]  D. Holmes,et al.  Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. , 2004, American heart journal.

[26]  M. Pfeffer,et al.  Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial. , 2004, European heart journal.

[27]  Deepak L. Bhatt,et al.  Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. , 1999, Circulation.

[28]  H. Pereira,et al.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial , 2001, The Lancet.

[29]  J. Rumsfeld,et al.  Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. , 2000, JAMA.

[30]  E. Topol,et al.  Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab. , 2002, The American journal of cardiology.

[31]  K. Fox,et al.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial , 2002, The Lancet.

[32]  E. Topol,et al.  Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. , 2003, JAMA.

[33]  W. O’Neill,et al.  Rescue angioplasty: does the concept need to be rescued? , 2004, Journal of the American College of Cardiology.

[34]  G. Wells,et al.  Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). , 2005, Journal of the American College of Cardiology.

[35]  K. Coyne,et al.  Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin: Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II) , 2001, Circulation.

[36]  J. Moses,et al.  Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. , 1999, Circulation.

[37]  S. Ellis,et al.  Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy. , 2004, American heart journal.

[38]  Gregg W. Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease , 2004 .

[39]  S. Silber,et al.  High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial. , 2004, Journal of the American College of Cardiology.

[40]  P. Serruys,et al.  Fibrinolytic therapy: is it a treatment of the past? , 2003, Circulation.

[41]  H. Hod,et al.  Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction , 2004, Circulation.

[42]  Deepak L. Bhatt,et al.  Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative , 2004 .

[43]  P. Serruys,et al.  A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators. , 1995, The New England journal of medicine.

[44]  Randomized, Placebo-Controlled Trial of Titrated Intravenous Lamifiban for Acute Coronary Syndromes , 2002, Circulation.

[45]  S. Kimmel,et al.  One-year clinical outcomes of protected and unprotected left main coronary artery stenting , 2003 .

[46]  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002 .

[47]  R. Kaplan,et al.  Volume-Outcome Relation for Physicians and Hospitals Performing Angioplasty for Acute Myocardial Infarction in New York State , 2001, Circulation.

[48]  G. Guyatt,et al.  Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[49]  Paul B. Watkins,et al.  Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation: A New Drug–Drug Interaction , 2003, Circulation.

[50]  Ron Waksman,et al.  Use of localised intracoronary β radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial ☆ , 2002 .

[51]  E. Topol,et al.  Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. , 2004, American heart journal.

[52]  P. Hartigan,et al.  Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to Medicine. , 1998, The American journal of cardiology.

[53]  Samin K. Sharma,et al.  Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis (ROSTER). , 2004, American heart journal.

[54]  P. Rentrop,et al.  Wiedereröffnung verschlossener Kranzgefäße im akuten Infarkt mit Hilfe von Kathetern , 1979 .

[55]  E. Antman,et al.  Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction. , 2004, Journal of the American College of Cardiology.

[56]  R A Schatz,et al.  Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial. , 2000, Circulation.

[57]  M. Hadamitzky,et al.  Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. , 2000, Journal of the American College of Cardiology.

[58]  A. Yeung,et al.  Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes: Results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) Pilot Trial , 2003, Circulation.

[59]  M. Bell,et al.  Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures. , 2004, American heart journal.

[60]  D Wybenga,et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.

[61]  W. O’Neill,et al.  Coronary angioplasty and Rotablator atherectomy trial (CARAT): Immediate and late results of a prospective multicenter randomized trial , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[62]  A. Denktas,et al.  Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes. , 2004, American heart journal.

[63]  Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). , 2000 .

[64]  R. Gibbons,et al.  829-5 Primary angioplasty in acute myocardial infarction with distal protection of the microcirculation: Principal results from the prospective, randomized EMERALD trial , 2004 .

[65]  K. Kuck,et al.  A randomized comparison of balloon angioplasty versus rotational atherectomy in complex coronary lesions (COBRA study). , 2000, European heart journal.

[66]  R. Califf,et al.  A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. , 1997 .

[67]  H. Crijns,et al.  Drug therapy or coronary angioplasty for the treatment of coronary artery disease: new insights. , 2001, American heart journal.

[68]  R. Kleiger,et al.  Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. , 1999, The New England journal of medicine.

[69]  M. A. Kellett,et al.  Outcomes of Percutaneous Coronary Interventions Performed at Centers Without and With Onsite Coronary Artery Bypass Graft Surgery , 2004 .

[70]  P. Serruys,et al.  Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients , 2004, Circulation.

[71]  Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. , 2004, Journal of the American College of Cardiology.

[72]  W. Wijns,et al.  Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. , 1998, Journal of the American College of Cardiology.

[73]  J. O’Keefe,et al.  Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. , 1999, Journal of the American College of Cardiology.

[74]  P. Lemos,et al.  Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease☆ , 2003 .

[75]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[76]  Jing Fang,et al.  Revascularization among patients with acute myocardial infarction complicated by cardiogenic shock and impact of American College of Cardiology/American Heart Association guidelines. , 2004, American Journal of Cardiology.

[77]  Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME). , 2004 .

[78]  P. Teirstein,et al.  Intracoronary Radiation Therapy Improves the Clinical and Angiographic Outcomes of Diffuse In-Stent Restenotic Lesions: Results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies , 2003, Circulation.

[79]  S. Yusuf,et al.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study ☆ , 2002 .

[80]  L Chiariello,et al.  A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. , 1997, The New England journal of medicine.

[81]  E. Topol,et al.  A preferred reperfusion strategy for acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[82]  P. Janský,et al.  International differences in in-hospital revascularization and outcomes following acute myocardial infarction (AMI) in ASSENT-2 , 2000 .

[83]  E. Topol,et al.  Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study , 2002, The Lancet.

[84]  A. Kastrati,et al.  Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. , 2003 .

[85]  W Wijns,et al.  Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis: A Randomized Trial , 2001, Circulation.

[86]  A. Kastrati,et al.  Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting. , 2004, European heart journal.

[87]  Samin K. Sharma,et al.  Two-year clinical follow-up of 90Sr/90 Y β-radiation versus placebo control for the treatment of in-stent restenosis , 2005 .

[88]  B. Brodie,et al.  Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy. , 1991, The American journal of cardiology.

[89]  R. Califf,et al.  The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. , 2003, The Journal of invasive cardiology.

[90]  A. Denktas,et al.  Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no‐reflow phenomenon , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[91]  Klaus Rasmussen,et al.  A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.

[92]  M. Marber,et al.  The open artery hypothesis: potential mechanisms of action. , 2000, Progress in cardiovascular diseases.

[93]  Raimund Erbel,et al.  Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis After Initial Balloon Angioplasty , 1999 .

[94]  Deepak L. Bhatt.  Aspirin resistance: more than just a laboratory curiosity. , 2004, Journal of the American College of Cardiology.

[95]  M. de Belder,et al.  Management of non ST-segment elevation acute coronary syndromes-continuing the search for the bad guys. , 2003, European heart journal.

[96]  Lawrence Joseph,et al.  Evidence for use of coronary stents: a hierarchical bayesian meta-analysis ☆ , 2003 .

[97]  M. Dalby,et al.  Transfer for Primary Angioplasty Versus Immediate Thrombolysis in Acute Myocardial Infarction: A Meta-Analysis , 2003, Circulation.

[98]  William S Weintraub,et al.  A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). , 2002, Journal of the American College of Cardiology.

[99]  岡松 健太郎.  Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes , 2004 .

[100]  H. Suryapranata,et al.  Randomised comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction , 1998 .

[101]  R. Tio,et al.  Clinical impact of abciximab on long‐term outcome after complex coronary angioplasty , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[102]  L. Wallentin,et al.  Natriuretic peptides in unstable coronary artery disease. , 2004, European heart journal.

[103]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[104]  P. Teirstein.  Living the dream of no restenosis. , 2001, Circulation.

[105]  M. Leon,et al.  The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. , 1998, Journal of the American College of Cardiology.

[106]  R. Bonow,et al.  Troponin I elevation and cardiac events after percutaneous coronary intervention. , 2003, American heart journal.

[107]  D. Holmes,et al.  Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization. , 2004, American heart journal.

[108]  L. Michalis,et al.  Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study). , 2000, European heart journal.

[109]  Deepak L. Bhatt,et al.  GuardWire emboli protection device is associated with improved myocardial perfusion grade in saphenous vein graft intervention. , 2004, American heart journal.

[110]  E. Antman,et al.  Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. , 2003, Journal of the American College of Cardiology.

[111]  E. Vicaut,et al.  Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study. , 2004, Journal of the American College of Cardiology.

[112]  Deepak L. Bhatt,et al.  Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). , 2003, Journal of the American College of Cardiology.

[113]  P. Hartigan,et al.  A Comparison of Angioplasty With Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease , 1992 .

[114]  F. Van de Werf,et al.  A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study. , 2001, European heart journal.

[115]  S. Silber.  Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients. , 2003, Journal of interventional cardiology.

[116]  G. Stone,et al.  Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. , 1999, Circulation.

[117]  E. Topol,et al.  Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. , 2003, JAMA.

[118]  C. Vrints,et al.  Study of antirestenosis with the BiodivYsio dexamethasone‐eluting stent (STRIDE): A first‐in‐human multicenter pilot trial , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[119]  K. Endresen,et al.  Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. , 1996, Journal of the American College of Cardiology.

[120]  P. Serruys,et al.  The Dutch experience in percutaneous transluminal angioplasty of narrowed saphenous veins used for aortocoronary arterial bypass. , 1991, The American journal of cardiology.

[121]  S. Pauker,et al.  A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. , 2003, Journal of the American College of Cardiology.

[122]  Hans-JürgenRupprecht,et al.  Randomized Evaluation of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation in High-Risk Patients , 1998 .

[123]  S. Greenhouse,et al.  A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial , 1999 .

[124]  E. Antman,et al.  Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.

[125]  Deepak L. Bhatt,et al.  Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials , 2002, Circulation.

[126]  D. Waters,et al.  Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. , 1999, The New England journal of medicine.

[127]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[128]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[129]  L. Hillis,et al.  Antiplatelet therapy for ischemic heart disease. , 2004, The New England journal of medicine.

[130]  P. Teirstein,et al.  Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. , 2002, The New England journal of medicine.

[131]  S. Mehta,et al.  Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. , 2004, The American journal of cardiology.

[132]  C. Cannon,et al.  The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes , 2004 .

[133]  M. Pan,et al.  Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. , 2004, American heart journal.

[134]  R. Ferrari,et al.  The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. , 2004, Journal of the American College of Cardiology.

[135]  P. Teirstein,et al.  New Frontiers in Interventional Cardiology: Intravascular Radiation to Prevent Restenosis , 2001, Circulation.

[136]  M. Pfisterer.  Long-Term Outcome in Elderly Patients With Chronic Angina Managed Invasively Versus by Optimized Medical Therapy: Four-Year Follow-Up of the Randomized Trial of Invasive Versus Medical Therapy in Elderly Patients (TIME) , 2004, Circulation.

[137]  G. Stone,et al.  Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. , 2003, Journal of the American College of Cardiology.

[138]  C. Di Mario,et al.  Randomized Comparison of Coronary Stent Implantation Under Ultrasound or Angiographic Guidance to Reduce Stent Restenosis (OPTICUS Study) , 2001, Circulation.

[139]  C. W. Barth,et al.  Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. , 2004, American heart journal.

[140]  C. Cannon.  Evidence-based risk stratification to target therapies in acute coronary syndromes. , 2002, Circulation.

[141]  Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. , 2002, JAMA.

[142]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[143]  J. Bassand.  Improving the quality and dissemination of guidelines: the quest for the Holy Grail. , 2000, European heart journal.

[144]  M. Bell,et al.  Clopidogrel versus ticlopidine after intracoronary stent placement. , 1999, Journal of the American College of Cardiology.

[145]  P. Serruys,et al.  A multicentre European registry of intraluminal coronary beta brachytherapy. , 2003, European heart journal.

[146]  D. Holmes,et al.  Coronary artery stents. , 2000, JAMA.

[147]  P. Théroux,et al.  Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators. , 2001, American Journal of Cardiology.

[148]  K. Karsch,et al.  Who wants his plaque sealed? , 2003, European heart journal.

[149]  P. Fitzgerald,et al.  Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. , 2000, Circulation.

[150]  P. Teirstein,et al.  Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. , 2001, The New England journal of medicine.

[151]  F. Verheugt.  Lyse now, stent later: the grace of GRACIA , 2004, The Lancet.

[152]  P. Steg,et al.  Impact of Prehospital Thrombolysis for Acute Myocardial Infarction on 1-Year Outcome: Results From the French Nationwide USIC 2000 Registry , 2004, Circulation.

[153]  R. Blindt,et al.  Evaluation of a high-dose dexamethasone-eluting stent. , 2004, The American journal of cardiology.

[154]  F. Schiele,et al.  Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies--with and without intravascular ultrasound guidance. RESIST Study Group. REStenosis after Ivus guided STenting. , 1998, Journal of the American College of Cardiology.

[155]  P. Teirstein,et al.  Randomized Trial of 90Sr/90Y &bgr;-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis , 2002, Circulation.

[156]  K. Teo,et al.  Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). , 1999, Circulation.

[157]  W. Gibler,et al.  A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes. , 2003, American heart journal.

[158]  Patrick W Serruys,et al.  Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. , 2004, Journal of the American College of Cardiology.

[159]  A. Colombo,et al.  A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[160]  W. Rogers,et al.  The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.

[161]  Habib Samady,et al.  Comparison between visual assessment and quantitative angiography versus fractional flow reserve for native coronary narrowings of moderate severity. , 2002, The American journal of cardiology.

[162]  Epilog Investigators,et al.  Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[163]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[164]  G. Montalescot,et al.  Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. , 2004, JAMA.

[165]  J. Lasala,et al.  Randomized Comparison of Ticlopidine and Clopidogrel After Intracoronary Stent Implantation in a Broad Patient Population , 2001, Circulation.

[166]  J. Popma,et al.  Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice , 2005, Circulation.

[167]  P. Armstrong,et al.  Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. , 2004, European heart journal.

[168]  T. Harr,et al.  Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease. A meta-analysis of randomized controlled trials. , 2004, European heart journal.

[169]  Utsch,et al.  A COMPARISON OF HIRUDIN WITH HEPARIN IN THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY P , 2001 .

[170]  H. Suryapranata,et al.  Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. , 2003, Journal of the American College of Cardiology.

[171]  P. Teirstein,et al.  Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. , 2000, Circulation.

[172]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[173]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[174]  Does it matter where you go with an acute myocardial infarction? , 2001, European heart journal.

[175]  P. Serruys,et al.  Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[176]  Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. , 1998, The New England journal of medicine.

[177]  S. Rohde,et al.  Stent or angioplasty after recanalization of chronic coronary occlusions? (The SARECCO Trial). , 1999, The American journal of cardiology.

[178]  H. Figulla,et al.  Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. , 2004, Journal of the American College of Cardiology.

[179]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[180]  S. de Servi,et al.  Non-ST-elevation acute coronary syndrome in the elderly: treatment strategies and 30-day outcome. , 2004, American heart journal.

[181]  S. Steinhubl,et al.  Clinical Implications of Percutaneous Coronary Intervention-Clopidogrel in Unstable angina to prevent Recurrent Events (PCI-CURE) Study: A US Perspective , 2002, Circulation.

[182]  Antonio Colombo,et al.  Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) , 1998, The Lancet.

[183]  W. O’Neill,et al.  Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. , 1991, Annals of internal medicine.

[184]  H. Suryapranata,et al.  Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction , 1997, Heart.

[185]  E. Topol,et al.  Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). , 2002, American heart journal.

[186]  H. Arendrup,et al.  Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. , 1997, Circulation.

[187]  E. Topol,et al.  Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). , 2004, The American journal of cardiology.

[188]  U. Zeymer,et al.  Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK) , 2004 .

[189]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[190]  W. Boden,et al.  Long-term follow-up of patients with increased cardiac troponin concentrations following percutaneous coronary intervention. , 2002, The American journal of cardiology.

[191]  N. Geller,et al.  Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. , 1997, Circulation.

[192]  R. Califf,et al.  Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada , 2004 .

[193]  J. Golmard,et al.  Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes. , 2004, American heart journal.

[194]  The association between hospital volume and survival after acute myocardial infarction in elderly patients. , 1999 .

[195]  T. Investigators.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.

[196]  Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. , 1998, The New England journal of medicine.

[197]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[198]  L. Liao,et al.  Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. , 2001, Journal of the American College of Cardiology.

[199]  J. J. Griffin,et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.

[200]  L. Wilkins.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[201]  E. Topol,et al.  Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial* , 2002, Circulation.

[202]  B. Ruck,et al.  Cocktail attenuation of rotational ablation flow effects (CARAFE) study: pilot. , 1996, Catheterization and cardiovascular diagnosis.

[203]  W. Daniel,et al.  Initial experience with the Endicor X-sizer thrombectomy device in patients with ST segment elevation myocardial infarction , 2002, Zeitschrift für Kardiologie.

[204]  E. Antman,et al.  Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. , 2004, European heart journal.

[205]  A. Cohen-Solal,et al.  Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes: Observations From the Global Registry of Acute Coronary Events (GRACE) , 2004, Circulation.

[206]  E. Topol,et al.  Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. , 2004, JAMA.

[207]  F H Sheehan,et al.  The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. , 1987, Circulation.

[208]  P. Teirstein,et al.  Rotational atherectomy (stentablation) in a lesion with stent underexpansion due to heavily calcified plaque , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[209]  Nader Rifai,et al.  Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide , 2002, Circulation.

[210]  V Hombach,et al.  A randomized trial of elective stenting after balloon recanalization of chronic total occlusions. , 1999, Journal of the American College of Cardiology.

[211]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[212]  B. Chaitman,et al.  Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. , 1995, The New England journal of medicine.

[213]  Elliott M. Antman,et al.  Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts , 2004, Circulation.

[214]  G. Stone,et al.  Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.

[215]  G. Stone,et al.  Non–Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary Lesions: Angiographic Follow-Up of the DELIVER Clinical Trial , 2004, Circulation.

[216]  W. Dassen,et al.  Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study , 1999, Heart.

[217]  D. Morrow,et al.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes☆ , 2002 .

[218]  J. Stauffer,et al.  Use of sirolimus‐eluting coronary stents in routine clinical practice , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[219]  N. Pijls.  Is it time to measure fractional flow reserve in all patients? , 2003, Journal of the American College of Cardiology.

[220]  H. H. Veloso,et al.  Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: a meta-analysis of randomized, controlled trials. , 2004, American heart journal.

[221]  J. Henriques,et al.  Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours. , 2003, Journal of the American College of Cardiology.

[222]  S. Yusuf,et al.  Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial , 2004, Circulation.

[223]  T. Meinertz,et al.  The IST Registry , 2002, Zeitschrift für Kardiologie.

[224]  Fernando Alfonso,et al.  Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. , 2004, Journal of the American College of Cardiology.

[225]  Samin K. Sharma,et al.  Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing. , 2004, The American journal of cardiology.

[226]  Jerome Sacks,et al.  Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry). , 2004, The American journal of cardiology.

[227]  R. Mehran,et al.  Two-year follow-up after beta and gamma intracoronary radiation therapy for patients with diffuse in-stent restenosis. , 2001, The American journal of cardiology.

[228]  G. Maurer,et al.  Intracoronary Thrombectomy With the X-Sizer Catheter System Improves Epicardial Flow and Accelerates ST-Segment Resolution in Patients With Acute Coronary Syndrome: A Prospective, Randomized, Controlled Study , 2002, Circulation.

[229]  V. Hasselblad,et al.  Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. , 2004, JAMA.

[230]  A. Kastrati,et al.  A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. , 2004, The New England journal of medicine.

[231]  J. Tcheng.  Primary angioplasty in acute myocardial infarction , 2002 .

[232]  H. Krumholz,et al.  Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: does the evidence support current procedure volume minimums? , 2004, Journal of the American College of Cardiology.

[233]  James Vayda,et al.  Aspirin, heparin, or both to treat acute unstable angina , 1989 .

[234]  F. Neumann,et al.  A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. , 2003, Journal of the American College of Cardiology.

[235]  P. Fitzgerald,et al.  'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). , 1998, Circulation.

[236]  G. Stone,et al.  Drug‐eluting stent task force: Final report and recommendations of the working committees on cost‐effectiveness/economics, access to care, and medicolegal issues , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[237]  C. Cannon,et al.  Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategy. , 2003, Circulation.

[238]  U. Zeymer,et al.  Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty and Medical Therapy in Stable Survivors of Acute Myocardial Infarction With Single Vessel Disease: A Study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte , 2003, Circulation.

[239]  Samin K. Sharma,et al.  A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). , 2002, The American journal of cardiology.

[240]  T. Investigators.  Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. , 1997, Circulation.

[241]  Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II.  Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II , 1997, The Lancet.

[242]  W. O’Neill,et al.  Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy , 2004, Circulation.

[243]  Lawrence Joseph,et al.  A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents , 2004, The Lancet.

[244]  J. Burchenal,et al.  Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. , 1998, Circulation.

[245]  Antonio Colombo,et al.  Direct Stenting with TAXUS Stents Seems to be as Safe and Effective as with Predilatation , 2004, Herz.

[246]  M. Pfisterer,et al.  A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. , 1999, European heart journal.

[247]  R. Bersin,et al.  Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS). , 2001, The American journal of cardiology.

[248]  L. Mauri,et al.  Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. , 2002, The American journal of cardiology.

[249]  A. Jacobs,et al.  Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[250]  S. Redwood,et al.  Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). , 2002, Journal of the American College of Cardiology.

[251]  S. Pocock,et al.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. , 1999, The New England journal of medicine.

[252]  G. Stone,et al.  Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. , 2000, The American journal of cardiology.

[253]  M. Gawaz,et al.  Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement , 2003, Thrombosis and Haemostasis.

[254]  E. Ohman,et al.  Relation Between Hospital Intra-Aortic Balloon Counterpulsation Volume and Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock , 2003, Circulation.

[255]  M. Aschermann,et al.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. , 2003, European heart journal.

[256]  T. LeJemtel,et al.  Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. , 2004, Journal of the American College of Cardiology.

[257]  M. Keltai,et al.  Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome). , 1999, European heart journal.

[258]  B. Meier.  Plaque sealing by coronary angioplasty , 2004, Heart.

[259]  F. Fernández‐Avilés,et al.  Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial , 2004, The Lancet.

[260]  A. Çengel,et al.  Use of intracoronary adenosine for the management of slow–no‐reflow phenomenon during percutaneous interventions , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[261]  G. Specchia,et al.  Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2002, European heart journal.

[262]  William Wijns,et al.  Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.

[263]  E. Topol,et al.  Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. , 1994, Circulation.

[264]  P. Touboul,et al.  Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.

[265]  J. Hung,et al.  Treatment of slow/no‐reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[266]  P. Serruys,et al.  Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameter. , 2004, The American journal of cardiology.

[267]  E. Topol,et al.  Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. , 1993, Journal of the American College of Cardiology.

[268]  Deepak L. Bhatt,et al.  Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. , 2002, Journal of the American College of Cardiology.

[269]  P. Barragan,et al.  Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction , 2001 .

[270]  F. Botto,et al.  Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes. , 2004, European heart journal.

[271]  G. Stone,et al.  Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. , 2000, The New England journal of medicine.

[272]  R. Gibbons,et al.  Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. , 2002, European heart journal.

[273]  Deepak L. Bhatt,et al.  Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. , 2004, The American journal of cardiology.

[274]  AlbertSchömig,et al.  Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis , 2003 .

[275]  S. Marsch,et al.  A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. , 2003, Journal of the American College of Cardiology.

[276]  M. Leon,et al.  Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. , 1995, Journal of the American College of Cardiology.

[277]  P. Serruys,et al.  Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease , 2004, Circulation.

[278]  M. Hadamitzky,et al.  Predictive factors of restenosis after coronary stent placement. , 1997, Journal of the American College of Cardiology.

[279]  J. Ottervanger,et al.  Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction. , 2004, Journal of the American College of Cardiology.

[280]  S. Silber,et al.  Rotational Atherectomy Does Not Reduce Recurrent In-Stent Restenosis: Results of the Angioplasty Versus Rotational Atherectomy for Treatment of Diffuse In-Stent Restenosis Trial (ARTIST) , 2002, Circulation.

[281]  N. Geller,et al.  The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. , 1994, Journal of the American College of Cardiology.

[282]  Werner Klein,et al.  Medical Practice Guidelines. Separating science from economics. , 2003, European heart journal.

[283]  P. Teirstein,et al.  Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis. , 1999, Circulation.

[284]  Christopher B. Granger,et al.  From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). , 2003 .

[285]  P. Serruys,et al.  Elective sirolimus‐eluting stent implantation for left main coronary artery disease: Six‐month angiographic follow‐up and 1‐year clinical outcome , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[286]  V. Hasselblad,et al.  Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials. , 2004, American heart journal.

[287]  M. Bertrand,et al.  Late is perhaps not ... too late for primary PCI in acute myocardial infarction. , 2002, European heart journal.

[288]  R. Califf,et al.  A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease , 1993 .

[289]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[290]  J. J. Griffin,et al.  Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial). , 2004, The American journal of cardiology.

[291]  Robert Parrish,et al.  Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. , 2002, JAMA.

[292]  P. Teirstein,et al.  Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents , 2004, Circulation.

[293]  C. Bauters,et al.  Six-month quantitative angiographic follow-up of < 50% diameter stenoses dilated during multilesion percutaneous transluminal coronary angioplasty. , 1993, The American journal of cardiology.

[294]  B. Gersh,et al.  Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. , 2003, European heart journal.

[295]  E. Antman,et al.  Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. , 2002, European heart journal.

[296]  H. Suryapranata,et al.  Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. , 2004, European heart journal.

[297]  H. Heidbuchel,et al.  Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial , 2002, Circulation.

[298]  S. Silber,et al.  Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). , 2004, Journal of the American College of Cardiology.

[299]  F. Ragmin.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[300]  L. Parsons,et al.  Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). , 2002, Journal of the American College of Cardiology.

[301]  E. Antman,et al.  Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment? , 2004, The American journal of cardiology.

[302]  William W O'Neill,et al.  A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. , 2002, Journal of the American College of Cardiology.

[303]  M. Whooley,et al.  Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. , 1997, JAMA.

[304]  M. Schwaiger,et al.  A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[305]  R. Califf,et al.  Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial. , 2000, Journal of the American College of Cardiology.

[306]  E. Topol,et al.  Recognition of the importance of embolization in atherosclerotic vascular disease. , 2000, Circulation.

[307]  A. Lincoff.  Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where? , 2003, American heart journal.

[308]  S. Nekolla,et al.  Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. , 2004, JAMA.

[309]  R. Califf,et al.  Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. , 2004, JAMA.

[310]  R. McKay.  "Ischemia-guided" versus "early invasive" strategies in the management of acute coronary syndrome/non-ST-segment elevation myocardial infarction: the interventionalist's perspective. , 2003, Journal of the American College of Cardiology.

[311]  M. Togni,et al.  Percutaneous coronary interventions in Europe 1992-2001. , 2004, European heart journal.

[312]  P. Serruys,et al.  Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry). , 2004, The American journal of cardiology.

[313]  F. Zijlstra.  Angioplasty vs thrombolysis for acute myocardial infarction: a quantitative overview of the effects of interhospital transportation. , 2003, European heart journal.

[314]  H. White,et al.  Safety and efficacy of enoxaparin vs. unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes. who receive tirofiban and aspirin ☆ , 2004 .

[315]  J. T. ten Berg,et al.  Primary stenting of occluded native coronary arteries: final results of the Primary Stenting of Occluded Native Coronary Arteries (PRISON) study. , 2004, American heart journal.

[316]  R. Baglini,et al.  Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function. , 2004, The American journal of cardiology.

[317]  Patrick W Serruys,et al.  Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”: The R apamycin-E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) Registry , 2004, Circulation.

[318]  J. Christenson,et al.  In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. , 2004, The American journal of cardiology.

[319]  M. Gotsman,et al.  Stents in total occlusion for restenosis prevention. The multicentre randomized STOP study. The Israeli Working Group for Interventional Cardiology. , 2000, European heart journal.

[320]  P. Berger.  Clopidogrel instead of ticlopidine after coronary stent placement: is the switch justified? , 2000, American heart journal.

[321]  H. Gray,et al.  Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents. , 2000, American heart journal.

[322]  A. Angelini,et al.  Distal Protection With a Filter Device During Coronary Stenting in Patients With Stable and Unstable Angina , 2004, Circulation.

[323]  R. de Caterina,et al.  Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. , 2004, European heart journal.

[324]  M. Gyöngyösi,et al.  Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion—results of the Austrian multi-centre randomized ReoPro-BRIDGING study , 2005 .

[325]  A. Kastrati,et al.  A RANDOMIZED COMPARISON OF ANTIPLATELET THERAPY AFTER THE PLACEMENT OF CORONARY ARTERY STENTS , 1996 .

[326]  S. Pocock,et al.  Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. , 2004, European heart journal.

[327]  D. Baim,et al.  Percutaneous treatment of protected and unprotected left main coronary stenoses with new devices: immediate angiographic results and intermediate-term follow-up. , 1997, Journal of the American College of Cardiology.

[328]  H. White,et al.  Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. , 2003, Journal of the American College of Cardiology.

[329]  A. Siegbahn,et al.  Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators. , 1999, Lancet.

[330]  Samin K. Sharma,et al.  Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. , 2004, The American journal of cardiology.

[331]  P. Serruys,et al.  Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. , 2004, The American journal of cardiology.

[332]  M. Simoons.  Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial , 2001, The Lancet.

[333]  P. Serruys,et al.  Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. , 2004, American heart journal.

[334]  M. Bertrand,et al.  Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). , 2000, Circulation.

[335]  E. Topol,et al.  Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. , 2001, American heart journal.

[336]  D. Holmes,et al.  Applicability of distal protection for aortocoronary vein graft interventions in clinical practice , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[337]  DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. , 2004 .

[338]  D. Freimark,et al.  Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction. , 2003, American heart journal.

[339]  R. Califf,et al.  Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada: Comparison of Patients Enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I , 2004, Circulation.

[340]  P. H. van der Voort,et al.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.

[341]  Brent A. Johnson,et al.  Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy). , 2004, The American journal of cardiology.

[342]  A. Kastrati,et al.  Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel , 2004, Circulation.

[343]  E. Braunwald,et al.  Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy). , 2004, The American journal of cardiology.

[344]  R. Ligon,et al.  Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. , 1999, Journal of the American College of Cardiology.

[345]  R. Schiele,et al.  Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. , 2001, American heart journal.

[346]  L. Wallentin,et al.  Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study , 2002, The Lancet.

[347]  W. Boden.  "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era. , 2003, Journal of the American College of Cardiology.

[348]  R. Califf,et al.  Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators. , 2001, Journal of the American College of Cardiology.

[349]  D. Baim,et al.  Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials , 2004, Circulation.

[350]  J. Ottervanger,et al.  Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. , 1999, The New England journal of medicine.

[351]  P. Teirstein,et al.  Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators. , 1999, Circulation.

[352]  J. Stauffer,et al.  A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. , 2005, Journal of the American College of Cardiology.

[353]  L. Ohno-Machado,et al.  No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. , 2003, American heart journal.

[354]  S. Yusuf,et al.  Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study , 2003, Circulation.

[355]  A. Kastrati,et al.  Loading With 600 mg Clopidogrel in Patients With Coronary Artery Disease With and Without Chronic Clopidogrel Therapy , 2004, Circulation.

[356]  V. Hasselblad,et al.  Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions. , 2003, The American journal of cardiology.

[357]  C. Macaya,et al.  Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). , 1998, Circulation.

[358]  F. Crea,et al.  A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery: five year clinical follow up , 2004, Heart.

[359]  E. Fleck,et al.  Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. , 1998, Circulation.

[360]  C. Hofer,et al.  Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[361]  J. M. Bloom.  Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. , 1998, The New England journal of medicine.

[362]  A. Colombo,et al.  A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. , 1996, Circulation.

[363]  W. Klein,et al.  Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC) , 1997, Circulation.

[364]  W. O’Neill,et al.  A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. , 1998, Journal of the American College of Cardiology.

[365]  G. Musumeci,et al.  Abciximab improves 6-month clinical outcome after rescue coronary angioplasty. , 2002, American heart journal.

[366]  F. Fernández‐Avilés,et al.  Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. , 1999, Journal of the American College of Cardiology.

[367]  M. Savage,et al.  Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II) , 1995, Circulation.

[368]  E. Topol,et al.  Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features , 2004, Circulation.

[369]  S. Silber.  Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies? , 2004, Journal of interventional cardiology.

[370]  H. Suryapranata,et al.  Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. , 2000, European heart journal.

[371]  Marc Cohen.  The role of low-molecular-weight heparin in the management of acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[372]  M. de Belder,et al.  A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. , 2004, Journal of the American College of Cardiology.

[373]  A Gruntzig,et al.  Transluminal dilatation of coronary-artery stenosis. , 1978, Lancet.

[374]  G. Stone,et al.  Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts , 2003, Circulation.

[375]  C. Di Mario,et al.  Randomized Evaluation of Polytetrafluoroethylene‐Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial , 2003, Circulation.

[376]  R. Kornowski,et al.  Preliminary experiences using X‐sizer catheter for mechanical thrombectomy of thrombus‐containing lesions during acute coronary syndromes , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[377]  A. Pichard,et al.  Twelve Versus Six Months of Clopidogrel to Reduce Major Cardiac Events in Patients Undergoing &ggr;-Radiation Therapy for In-Stent Restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 Versus WRIST PLUS , 2002, Circulation.

[378]  G. Luca,et al.  Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty☆ , 2004 .

[379]  R. Waksman,et al.  Major noncardiac surgery following coronary stenting: When is it safe to operate? , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[380]  G. Guyatt,et al.  Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials , 2000, BMJ : British Medical Journal.

[381]  K. Coyne,et al.  Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II) , 2002 .

[382]  M. Leon,et al.  Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.

[383]  S. Yusuf,et al.  The evolving role of direct thrombin inhibitors in acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[384]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[385]  E. Topol,et al.  Lack of adverse clopidogrel-atorvastatin clinical interaction. , 2004, The American journal of cardiology.

[386]  E. Topol,et al.  Abciximab-facilitated percutaneous coronary intervention and long-term survival--a prospective single-center registry. , 2003, European heart journal.

[387]  O. Penn,et al.  Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.